Includes: background on nicotine pharmacology; corporate relationship between British-American Tobacco Co. and Brown and Williamson Tobacco Co.; FDA letters to tobacco manufacturers; bibliography of industry-funded research; marketing of cigarettes and smokeless tobacco in the U.S.; citizen petitions and submitted comments; statements by David A. Kessler, M.D., Commissioner of Food and Drugs, on nicotine-containing cigarettes and on the control and manipulation of nicotine in cigarettes; and remarks by David A. Kessler, M.D., The Samuel Rubin Program, The Columbia University School of Law, March 8, 1995.